<!DOCTYPE html PUBLIC "-//W3C//DTD HTML 4.0 Transitional//EN" "http://www.w3.org/TR/REC-html40/loose.dtd">
<html><body><html><body><section class="summaryOfFindings"><div class="section-header section-collapse-header" id="CD008676-sec-0008" lang="en"> <h2 class="title section-collapse-title"> Summary of findings <i aria-hidden="true" class="fa fa-caret-up section-collapse-icon"></i> </h2> </div> <section class="summaryOfFindings" lang="en"><div class="section-header" id="CD008676-sec-0008"></div> <div class="table" id="CD008676-tbl-0001"> <a href="#0" class="open-table-viewer open-in-figure-viewer">Open in table viewer</a><div class="table-heading">
<span class="table-label">Summary of findings 1.</span> <span class="table-title">Summary of findings</span>
</div>
<table class="summary-of-findings framed">
<tbody>
<tr class="separated">
<th scope="col" align="" valign="" colspan="7" rowspan="1" class="headercell"> <p><b>Chlorhexidine mouthrinse compared with placebo/control mouthrinse/no mouthrinse for gingival health</b> </p> </th> </tr>
<tr class="separated">
<td align="" valign="" colspan="7" rowspan="1" bgcolor="#ffffff"> <p><b>Patient or population:</b> adults and children with gingivitis </p> <p><b>Settings:</b> any </p> <p><b>Intervention:</b> chlorhexidine mouthrinse </p> <p><b>Comparison:</b> placebo/control mouthrinse or no mouthrinse </p> </td> </tr>
<tr class="separated">
<th scope="col" align="" valign="top" colspan="1" rowspan="3" class="headercell"> <p><b>Outcomes</b> </p> </th> <th scope="col" align="" valign="top" colspan="2" rowspan="1" class="headercell table-tint"> <p><b>Illustrative comparative risks* (95% CI)</b> </p> </th> <th scope="col" align="" valign="top" colspan="1" rowspan="3" class="headercell"> <p><b>Relative effect<br>(95% CI)</b> </p> </th> <th scope="col" align="" valign="top" colspan="1" rowspan="3" class="headercell"> <p><b>Number of participants<br>(studies)</b> </p> </th> <th scope="col" align="" valign="top" colspan="1" rowspan="3" class="headercell"> <p><b>Quality of the evidence<br>(GRADE)</b> </p> </th> <th scope="col" align="" valign="top" colspan="1" rowspan="3" class="headercell"> <p><b>Comments</b> </p> </th> </tr>
<tr class="separated">
<th scope="col" align="" valign="top" colspan="1" rowspan="1" class="headercell table-tint"> <p><b>Assumed risk</b> </p> </th> <th scope="col" align="" valign="top" colspan="1" rowspan="1" class="headercell table-tint"> <p><b>Corresponding risk</b> </p> </th> </tr>
<tr class="separated">
<th scope="col" align="" valign="top" colspan="1" rowspan="1" class="headercell table-tint"> <p><b>Control</b> </p> </th> <th scope="col" align="" valign="top" colspan="1" rowspan="1" class="headercell table-tint"> <p><b>Chlorhexidine</b> </p> </th> </tr>
<tr class="separated">
<td align="" valign="top" colspan="1" rowspan="1" bgcolor="#ffffff"> <p><b>Gingival Index 4 to 6 weeks</b> (Löe and Silness Gingival Index) (0 to 3 on an increasing scale) </p> </td> <td align="" valign="top" colspan="1" rowspan="1" class="table-tint table-highlight"> <p>The mean gingivitis scores ranged across control groups from 0.17 to 1.40<sup>1</sup></p> </td> <td align="" valign="top" colspan="1" rowspan="1" class="table-tint table-highlight"> <p>The mean gingivitis score in the chlorhexidine group was 0.21 lower (0.11 to 0.31 lower) </p> </td> <td align="" valign="top" colspan="1" rowspan="1" bgcolor="#ffffff"></td> <td align="" valign="top" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>805</p> <p>(10 trials)</p> </td> <td align="" valign="top" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>⊕⊕⊕⊕<sup>2,3</sup><br><b>high</b> </p> </td> <td align="" valign="top" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>The effect size at 6 months was similar</p> <p>Insufficient evidence for differences in effect size for different chlorhexidine concentration or frequency of use </p> <p>Insufficient evidence to determine the effect size in individuals with moderate or severe levels of gingival inflammation on average (mean GI scores 1.1 to 3) </p> </td> </tr>
<tr class="separated">
<td align="" valign="top" colspan="1" rowspan="1" bgcolor="#ffffff"> <p><b>Plaque 4 to 6 weeks</b> </p> <p>(various increasing scales including Plaque Index (0 to 3 scale) and Turesky Modification of the Quigley and Hein Index (0 to 5 scale)) </p> </td> <td align="" valign="top" colspan="1" rowspan="1" class="table-tint table-highlight"> <p>Plaque Index ranged from 0.75 to 1.06</p> <p>Turesky Modification of the Quigley and Hein Index ranged from 1.2 to 3.3</p> </td> <td align="" valign="top" colspan="1" rowspan="1" class="table-tint table-highlight"> <p>The SMD was 1.45 lower in the chlorhexidine group indicating a large reduction in plaque from 1.00 to 1.90 standard deviations </p> </td> <td align="" valign="top" colspan="1" rowspan="1" bgcolor="#ffffff"></td> <td align="" valign="top" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>950</p> <p>(12 trials)</p> </td> <td align="" valign="top" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>⊕⊕⊕⊕<sup>2,3</sup><br><b>high</b> </p> </td> <td align="" valign="top" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>The effect for the Plaque Index (4 trials; 223 participants) was 0.58 (95% CI 0.39 to 0.78) lower </p> <p>The effect for the Turesky Modification of the Quigley and Hein Index (5 trials; 546 participants) was 0.78 (95% CI 0.70 to 0.85) lower </p> <p>There were also large effects for the plaque at 6 months</p> </td> </tr>
<tr class="separated">
<td align="" valign="top" colspan="1" rowspan="1" bgcolor="#ffffff"> <p><b>Tooth staining 4 to 6 weeks</b> </p> <p>(various increasing scales)</p> </td> <td align="" valign="top" colspan="1" rowspan="1" class="table-tint table-highlight"> <p>The mean tooth staining score was measured on different scales</p> </td> <td align="" valign="top" colspan="1" rowspan="1" class="table-tint table-highlight"> <p>The SMD for tooth staining in the chlorhexidine group was<br>1.07 (0.80 to 1.34) standard deviations higher </p> </td> <td align="" valign="top" colspan="1" rowspan="1" bgcolor="#ffffff"></td> <td align="" valign="top" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>415</p> <p>(8 trials)</p> </td> <td align="" valign="top" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>⊕⊕⊕⊝<sup>4</sup><br><b>moderate</b> </p> </td> <td align="" valign="top" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Data have not been converted to original scale as many different scales are used. The SMD effect size is considered large </p> <p>There were also 2 trials presenting dichotomous data showing large significant effect RR 5.41 (95% CI 2.03 to 14.47) </p> <p>There was also a large effect for tooth staining for chlorhexidine at 7 to 12 weeks and 6 months </p> </td> </tr>
<tr class="separated">
<td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p><b>Other adverse effects</b> </p> </td> <td align="" valign="" colspan="6" rowspan="1" class="table-tint table-highlight"> <p>22 trials reported at least 1 adverse effect apart from extrinsic tooth staining and calculus formation in the chlorhexidine rinse arms. The adverse effects most commonly reported were taste disturbance/alteration (reported in 11 trials), effects on the oral mucosa including mucosal irritation, soreness, mild desquamation, mucosal ulceration/erosions, oral mucosal lesions (reported in 13 trials) and a general burning sensation and/or a burning tongue (reported in 9 trials) </p> </td> </tr>
<tr class="separated">
<td align="" valign="" colspan="7" rowspan="1" bgcolor="#ffffff"> <p>*The basis for the <b>assumed risk</b> (e.g. the median control group risk across trials) is provided in footnotes. The <b>corresponding risk</b> (and its 95% CI) is based on the assumed risk in the comparison group and the <b>relative effect</b> of the intervention (and its 95% CI)<br><b>CI:</b> confidence interval; <b>GI:</b> Gingival Index; <b>RR:</b> risk ratio; <b>SMD:</b> standardised mean difference </p> </td> </tr>
<tr class="separated">
<td align="" valign="" colspan="7" rowspan="1" bgcolor="#ffffff"> <p>GRADE Working Group grades of evidence<br><b>High quality:</b> further research is very unlikely to change our confidence in the estimate of effect<br><b>Moderate quality:</b> further research is likely to have an important impact on our confidence in the estimate of effect and may change the estimate<br><b>Low quality:</b> further research is very likely to have an important impact on our confidence in the estimate of effect and is likely to change the estimate<br><b>Very low quality:</b> we are very uncertain about the estimate </p> </td> </tr>
</tbody>
<tfoot><tr>
<td colspan="7"> <div class="table-footnote"> <p><sup>1</sup>The mean gingivitis score for the control group was 0.93 (median is 1.0).<br><sup>2</sup>Although most trials included in the meta‐analyses were assessed as at high risk of bias we did not downgrade the GRADE assessments for this reason because we believe that further research is very unlikely to change our confidence in the estimate of effect.<br><sup>3</sup>Not downgraded for high heterogeneity as results consistent.<br><sup>4</sup>Downgraded as 8 trials at high risk of bias. </p> </div> </td> </tr></tfoot>
</table>
</div> </section></section></body></html></body></html>
